Notice2022-17855

Foreign-Trade Zone (FTZ) 30-Salt Lake City, Utah, Notification of Proposed Production Activity, Albion Laboratories, Inc. (Mineral Amino Acid Chelates), Ogden, Utah

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
August 19, 2022

Issuing agencies

Commerce DepartmentForeign-Trade Zones Board

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 160 (Friday, August 19, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 160 (Friday, August 19, 2022)]
[Notices]
[Page 51054]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-17855]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-35-2022]


Foreign-Trade Zone (FTZ) 30--Salt Lake City, Utah, Notification 
of Proposed Production Activity, Albion Laboratories, Inc. (Mineral 
Amino Acid Chelates), Ogden, Utah

    Albion Laboratories, Inc. (Albion) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facilities in Ogden, Utah within Subzone 30E. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on August 15, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status materials/components and 
specific finished products described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>.
    The proposed finished products include: calcium bisglycinate; 
calcium citrate malate; calcium potassium phosphate citrate; chromium 
nicotinate glycinate chelate; copper bisglycinate; dicalcium malate; 
dimagnesium malate; ferric glycinate; ferrous bisglycinate; magnesium 
creatine; magnesium bisglycinate; magnesium lysinate glycinate; 
manganese bisglycinate; selenium glycinate; and, zinc bisglycinate 
chelate (duty rate ranges from 3.7% to 6.5%).
    The proposed foreign-status materials and components include 
glycine (aminoacetic acid), citric acid, and malic acid (duty rate 
ranges from 4%-6%). The request indicates that glycine and citric acid 
are subject to antidumping/countervailing duty (AD/CVD) orders if 
imported from certain countries. The Board's regulations (15 CFR 
400.14(e)) require that merchandise subject to AD/CVD orders, or items 
which would be otherwise subject to suspension of liquidation under AD/
CVD procedures if they entered U.S. customs territory, be admitted to 
the zone in privileged foreign (PF) status (19 CFR 146.41). The request 
also indicates that all materials/components are subject to duties 
under section 301 of the Trade Act of 1974 (section 301), depending on 
the country of origin. The applicable section 301 decisions require 
subject merchandise to be admitted to FTZs in PF status.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#8ceaf8f6ccf8feede8e9a2ebe3fa"><span class="__cf_email__" data-cfemail="4026343a0034322124256e272f36">[email&#160;protected]</span></a>. The closing period for their receipt is September 28, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
<a href="/cdn-cgi/l/email-protection#1d59747c7378335b74736b786f5d696f7c7978337a726b"><span class="__cf_email__" data-cfemail="04406d656a612a426d6a7261764470766560612a636b72">[email&#160;protected]</span></a>.

    Dated: August 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-17855 Filed 8-18-22; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on August 19, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.